APA (7th ed.) Citation

Artone, S., Ray, S., Williams, J. J., Akbulut, K., Cordero, P., Gómez-Úriz, A. M., . . . Santis, S. D. (2025). The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn's disease-like ileitis. Journal of Crohn's & Colitis, 19(6), 1. https://doi.org/10.1093/ecco-jcc/jjaf083

Chicago Style (17th ed.) Citation

Artone, Serena, et al. "The Angiotensin Receptor Blocker, Losartan, Reduces Inflammation and Fibrosis, and Prevents Relapse of Fibrosis After Steroid-induced Remission, in Mice Prone to Crohn's Disease-like Ileitis." Journal of Crohn's & Colitis 19, no. 6 (2025): 1. https://doi.org/10.1093/ecco-jcc/jjaf083.

MLA (9th ed.) Citation

Artone, Serena, et al. "The Angiotensin Receptor Blocker, Losartan, Reduces Inflammation and Fibrosis, and Prevents Relapse of Fibrosis After Steroid-induced Remission, in Mice Prone to Crohn's Disease-like Ileitis." Journal of Crohn's & Colitis, vol. 19, no. 6, 2025, p. 1, https://doi.org/10.1093/ecco-jcc/jjaf083.